A New FDA Approval Brings New Psychiatric Risks

The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.

CME: Take the CME Post-Test for this Episode

Published On: 09/01/2025

Duration: 16 minutes, 42 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.